Sullivan Km

920 citations
20 papers · 707 indexed · h-index 14

Sullivan Km

20 papers receiving 665 citations

Peers

Sullivan Km
Comparison fields: 5 of 62
  • Hematology 555
  • Transplantation 29
  • Immunology 220
  • Genetics 85
  • Oncology 196
Replace Bengt Sallerfors with:
Bengt Sallerfors Sweden
Y Bonny Canada
Karl G. Blume United States
Michael R. Bishop United States
E. Di Bona Italy
WE Beschorner United States
Prentice Hg United Kingdom
H. Lumley United Kingdom
R Storb United States
Ž Pavletić United States
Sullivan Km relative to Bengt Sallerfors Sweden Bengt Sallerfors's profile →
Citations per field
00.5×1.5×
Bengt Sallerfors · 1×
Citations per year

Countries citing papers authored by Sullivan Km

Since Specialization
Citations

This map shows the geographic impact of Sullivan Km's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sullivan Km with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sullivan Km more than expected).

Fields of papers citing papers by Sullivan Km

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sullivan Km. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sullivan Km. The network helps show where Sullivan Km may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sullivan Km, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sullivan Km Line = papers co-authored together Sullivan Km links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
199725
2
Inositol 1,4,5-trisphosphate receptor activation and nuclear envelope assembly.
19962
3
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
199689
4
Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
19933
5
Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation.
199215
6
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
199125
7
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
199121
8
Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation.
199010
9
Current status of bone marrow transplantation.
198910
10
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
198943
11
Congress review: progress and prospects in bone marrow transplantation.
19896
12
Long-term complications of bone marrow transplantation.
19891
13
Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation.
198822
14
The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.
198735
15
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
198730
16
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
198731
17
Second marrow infusion for poor graft function after allogeneic marrow transplantation.
198643
18
Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease.
198492
19
Late complications after marrow transplantation.
1984104
20
Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation.
1981100

About Sullivan Km

Sullivan Km is a scholar working on Hematology, Emergency Medicine and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 707 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), Hematological disorders and diagnostics (3 papers), Transplantation: Methods and Outcomes (3 papers), Diabetic Foot Ulcer Assessment and Management (2 papers), Clinical practice guidelines implementation (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper), Corneal Surgery and Treatments (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Hematology (555 citations), Transplantation (29 citations) and Immunology (220 citations). Sullivan Km has collaborated with scholars based in United States and South Africa. Frequent co-authors include Thomas Ed, Appelbaum Fr, CD Buckner, PL Weiden, Deeg Hj, Rainer Storb, JE Sanders, Shulman Hm, Sanders Je and Nancy Flournoy. Their work appears in journals such as Transplantation Proceedings and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026